Circulating Fibronectin and Plasminogen Activator Inhibitor2 Levels as
Circulating Fibronectin and Plasminogen Activator Inhibitor-2 Levels as Possible Predictors of Recurrent Placental Syndrome: An Exploratory Study Gynecol Obstet Invest 2017; 82: 355 -360 - DOI: 10. 1159/000449385 © 2016 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4. 0
Circulating Fibronectin and Plasminogen Activator Inhibitor-2 Levels as Possible Predictors of Recurrent Placental Syndrome: An Exploratory Study Gynecol Obstet Invest 2017; 82: 355 -360 - DOI: 10. 1159/000449385 © 2016 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4. 0
Circulating Fibronectin and Plasminogen Activator Inhibitor-2 Levels as Possible Predictors of Recurrent Placental Syndrome: An Exploratory Study Gynecol Obstet Invest 2017; 82: 355 -360 - DOI: 10. 1159/000449385 © 2016 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4. 0
Circulating Fibronectin and Plasminogen Activator Inhibitor-2 Levels as Possible Predictors of Recurrent Placental Syndrome: An Exploratory Study Gynecol Obstet Invest 2017; 82: 355 -360 - DOI: 10. 1159/000449385 © 2016 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4. 0
Circulating Fibronectin and Plasminogen Activator Inhibitor-2 Levels as Possible Predictors of Recurrent Placental Syndrome: An Exploratory Study Gynecol Obstet Invest 2017; 82: 355 -360 - DOI: 10. 1159/000449385 © 2016 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4. 0
- Slides: 5
